BioCentury

7:00 AM GMT, Sep 6, 2010
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Results

MP4OX: Phase IIa data

In a double-blind, international Phase IIa trial in 51 severely injured trauma patients with lactic acidosis, 250 and 500 mL MP4OX each met

Read the full 235 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.